Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
20
RNAC Quote, Financials, Valuation and Earnings
Last price:
$6.79
Seasonality move
:
0.08%
Day range:
$6.41 - $6.83
52-week range:
$5.98 - $20.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
75.41x
P/B ratio:
568.21x
Volume:
111.1K
Avg. volume:
189.5K
1-year change:
-63.4%
Market cap:
$175.8M
Revenue:
$38.9M
EPS (TTM):
-$2.59
Earnings Data
Next earnings date for RNAC
Mar 12
2026
Most recent earnings per share
-$1.38
Missed by $0.75
(Nov 6/2025)
Consensus Estimate
-$0.63
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RNAC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/12/2026 | Q4 | $100.2K | -- | -- | -$0.79 | -- |
| 11/06/2025 | Q3 | $177.6K | $452K | -$1.38 | -$0.63 | -$0.75 |
| 08/08/2025 | Q2 | $812.5K | $298K | $0.60 | -$0.65 | $1.25 |
| 05/12/2025 | Q1 | $687.5K | $1.1M | -$0.68 | -- | -- |
| 03/13/2025 | Q4 | $100K | -- | -- | -- | -- |
| 11/07/2024 | Q3 | $1.8M | $387K | -$1.13 | -$0.55 | -$0.58 |
| 08/08/2024 | Q2 | $5.5M | $33.4M | $0.54 | -$0.10 | $0.64 |
| 05/08/2024 | Q1 | -- | $5.8M | -$10.50 | -$1.42 | -$9.08 |
| 03/07/2024 | Q4 | $2.5M | $8.3M | -$41.56 | -$1.50 | -$40.06 |
| 11/13/2023 | Q3 | -- | $6.6M | -$1.74 | -- | -- |
| 08/17/2023 | Q2 | -- | $5.2M | -$2.23 | -- | -- |
| 03/31/2023 | Q1 | -- | $5.9M | -$4.24 | -- | -- |
| 12/31/2022 | Q4 | -- | $16.8M | -$1.50 | -- | -- |
| 09/30/2022 | Q3 | -- | $20.7M | -$1.55 | -- | -- |
| 06/30/2022 | Q2 | -- | $39.3M | $1.74 | -- | -- |
| 03/31/2022 | Q1 | -- | $34M | $6.77 | -- | -- |
| 12/31/2021 | Q4 | -- | $29.9M | $2.96 | -- | -- |
| 09/30/2021 | Q3 | -- | $24.4M | -$4.66 | -- | -- |
| 06/30/2021 | Q2 | -- | $19.7M | $1.13 | -- | -- |
| 03/31/2021 | Q1 | -- | $11.1M | -$6.66 | -- | -- |
| 12/31/2020 | Q4 | -- | $12M | -$4.30 | -- | -- |
| 09/30/2020 | Q3 | -- | $4.6M | -$2.77 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$7.46 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$6.21 | -- | -- |
| 12/31/2019 | Q4 | -- | $6.7M | -$8.54 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$7.75 | -- | -- |
| 06/30/2019 | Q2 | -- | $13K | -$10.96 | -- | -- |
| 03/31/2019 | Q1 | -- | $10K | -$9.42 | -- | -- |
| 12/31/2018 | Q4 | -- | $903K | -$19.58 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$21.43 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$25.22 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$21.33 | -- | -- |
| 12/31/2017 | Q4 | -- | $17K | -$26.40 | -- | -- |
| 09/30/2017 | Q3 | -- | $27K | -$19.80 | -- | -- |
| 06/30/2017 | Q2 | -- | $26K | -$25.50 | -- | -- |
| 03/31/2017 | Q1 | -- | $137K | -$24.58 | -- | -- |
| 12/31/2016 | Q4 | -- | $2.9M | -$23.10 | -- | -- |
| 09/30/2016 | Q3 | -- | $1M | -$12.90 | -- | -- |
| 06/30/2016 | Q2 | -- | $2M | -$82.50 | -- | -- |
| 03/31/2016 | Q1 | -- | $2.1M | -$15.82 | -- | -- |
| 12/31/2015 | Q4 | -- | $2.1M | -$21.51 | -- | -- |
Cartesian Therapeutics, Inc. Earnings Questions
-
How Much did Cartesian Therapeutics, Inc. Generate in Revenue Last Quarter?
Cartesian Therapeutics, Inc. reported $452K worth of top line sales in its most recent quarter.
-
Did Cartesian Therapeutics, Inc. Beat Earnings Last Quarter?
Cartesian Therapeutics, Inc. announced earnings per share of -$1.38 which represents a miss of analyst forecast a -$0.63 per share.
-
Is Cartesian Therapeutics, Inc. Profitable?
Cartesian Therapeutics, Inc. reported $452K that represents $0.02 per share over the last quarter.
-
What is the Analyst Consensus for Cartesian Therapeutics, Inc. EPS Next Year?
Cartesian Therapeutics, Inc.'s earnings are forecast to decrease from -$4.48 per share to -$1.93 per share next year representing a decrease of -56.93%.
-
When is Cartesian Therapeutics, Inc.'s Earnings Date?
Cartesian Therapeutics, Inc.'s next earnings date is March 12, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
